Human Anti-Human MPL monoclonal Antibody, clone SFB360 [APC]

The objective of this study was to estimate phenotypic and genetic parameters for clutch and broodiness (BR) traits in turkeys and their relationship with body weight and egg production. Data on dam line hens was available and included: body weight at 18 wk of age (BW18), body weight at lighting (BWL, 29 to 33 wk), age at first egg (AFE), egg number (EN), rate of lay (RL), clutch length (CL), maximum clutch length (MCL), pause length (PL), maximum PL (MPL) and BR. BR was defined as the average number of consecutive pause days between clutches that was higher than the average PL per hen. Heritability estimates for BW18 and BWL were 0.50 and 0.53, respectively. The heritability for egg production, clutch, and pause traits varied from low (MPL = 0.15; BR = 0.15) to moderate (AFE = 0.22; EN = 0.28; RL = 0.29; CL = 0.21; MCL = 0.27; PL = 0.25). Genetic correlations were negative between body weight traits and EN (r(g) ((BW18, EN)) = -0.27; r(g(BWL, EN)) = -0.33) and CL (r(g(BW18, CL)) = -0.40; r(g(BWL, CL)) = -0.33). BR was negatively genetically correlated with EN (r(g(BR, EN)) = -0.85) and CL (r(g(BR, CL)) = -0.30), and positively genetically correlated with PL (r(g(BR, PL)) = 0.93) and AFE (r(g(BR, AFE)) = 0.21). EN had a positive (0.73) and a negative (-0.84) genetic correlation with CL and PL, respectively. Overall, the results of this study confirmed the negative (unfavorable) correlations between egg production and body weight. Despite unfavorable genetic and phenotypic correlations between egg production traits and those relating to BR, the inclusion of BR in a selection program through incorporation of clutch length traits and pause length traits is feasible. Integration of either clutch length traits or pause length traits in a selection index is likely to increase egg number while decreasing broodiness.

Background: Mutations in CALR observed in myeloproliferative neoplasms (MPN) were recently shown to be pathogenic via their interaction with MPL and the subsequent activation of the Janus Kinase - Signal Transducer and Activator of Transcription (JAK-STAT) pathway. However, little is known on the impact of those variant CALR proteins on endoplasmic reticulum (ER) homeostasis. Methods: The impact of the expression of Wild Type (WT) or mutant CALR on ER homeostasis was assessed by quantifying the expression level of Unfolded Protein Response (UPR) target genes, splicing of X-box Binding Protein 1 (XBP1), and the expression level of endogenous lectins. Pharmacological and molecular (siRNA) screens were used to identify mechanisms involved in CALR mutant proteins degradation. Coimmunoprecipitations were performed to define more precisely actors involved in CALR proteins disposal. Results: We showed that the expression of CALR mutants alters neither ER homeostasis nor the sensitivity of hematopoietic cells towards ER stress-induced apoptosis. In contrast, the expression of CALR variants is generally low because of a combination of secretion and protein degradation mechanisms mostly mediated through the ER-Associated Degradation (ERAD)-proteasome pathway. Moreover, we identified a specific ERAD network involved in the degradation of CALR variants. Conclusions: We propose that this ERAD network could be considered as a potential therapeutic target for selectively inhibiting CALR mutant-dependent proliferation associated with MPN, and therefore attenuate the associated pathogenic outcomes.